{
    "organizations": [],
    "uuid": "abe471811fb89f5019dd649f7875aa063288ed4f",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-bio-rad-gains-additional-us-fda-cl/brief-bio-rad-gains-additional-u-s-fda-clearances-idUSFWN1PH128",
    "ord_in_thread": 0,
    "title": "BRIEF-Bio-Rad Gains Additional U.S. FDA Clearances",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 22 (Reuters) - Bio Rad Laboratories Inc:\n* BIO-RAD GAINS ADDITIONAL U.S. FDA CLEARANCES FOR BLOOD TYPING PRODUCTS, EXPANDING ITS OFFERING FOR BLOOD TESTING MARKET Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-23T06:01:00.000+02:00",
    "crawled": "2018-01-23T18:11:37.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "bio",
        "rad",
        "laboratory",
        "inc",
        "gain",
        "additional",
        "fda",
        "clearance",
        "blood",
        "typing",
        "product",
        "expanding",
        "offering",
        "blood",
        "testing",
        "market",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}